LNTH | Lantheus Holdings, Inc.

Today
0.00
%
$
65.18
Beginners
Defensive

About Lantheus

Lantheus is an American company that develops, manufactures, sells, and distributes diagnostic tools and products to help clinicians diagnose cancer, cardiovascular and other diseases. Learn the latest information and analysis on the company, LNTH stock price today, stock news, how much one share costs and other information to help you make investment decisions. 

Check out Gainy to see insights on stock prices and more.

Lantheus was founded in 1956 and had an IPO in 2015. The company has headquarters in North Billerica, Massachusetts and operates worldwide. 

LNTH recently crossed the mid-cap threshold and has a market capitalization of $3.8 billion, which means the company has a huge potential to grow in the future. Lantheus expects to have a record year with revenue around $700 million.

The Lantheus stock price grew over 100% this year and 70% in one week alone after reporting great fourth quarter and full year 2021 financial results on February 24, 2022, as well as after the FDA approval for a new manufacturing facility.

Check back to this page for the LNTH stock quote or download Gainy to see if LNTH fits your portfolio and investment goals, as well as other stock quotes and recommendations that fit your portfolio and interests.

Market Data

Market
Capitalization
$
4.43B
30 days price change
10.31
%
Revenue Growth
Quarterly, YoY
125.80
%
Volume, Today
184.35K
EV/S
8.02
%
Net Profit Margin
TTM, ANNUAL
-6.89%

Ratings

4.67
bullish
Very bullish
Neutral
Bearish
Very Bearish
Very bullish
2
Bullish
1
Neutral
0
Bearish
0
Very Bearish
0
Price Target
$
36.33
Does it work for you
More information in Gainy App
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download on the App Store
Thank you!
Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking "Submit" you accept our Privacy Policy.